What’s New in Rosacea in 2022
149221492214922
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about exciting new developments in rosacea medications. Watch as he offers his most important advice for treating patients with this chronic skin condition.
� …
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about exciting new developments in rosacea medications. Watch as he offers his most important advice for treating patients with this chronic skin condition.
� … 
2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used prominently in acne vulgaris, and is also employed in many other dermatological conditions because of its molecular and pharmacological properties. In this article, we review the history of minocycli … 
One of my favorite aspects of attending conferences is the opportunity to ask respected experts in the field clinically relevant questions that I can take back to directly help my patients. I was really looking forward to attending the 2020 Skin of Color Update conference in person, but due to the ongoing COVID-19 pandemic, it was moved to a virtual format. I wondered if attending a virtual confer … 
Acne is the most common skin condition in the United States. Although it affects almost 50 million individuals annually, how it affects each person varies. Many epidemiologic studies have shown that acne is the most common presenting complaint in patients with Fitzpatrick skin types IV-VI. However, post-inflammatory hyperpigmentation is a common sequela of acne in patients of skin of color and a p … 